CHESTPublicationsCHEST Journal

CHEST Journal: Peer-Reviewed. Cutting-Edge.

Highlights from May

This month’s handpicked reading list

ASTHMA

Genetic Associations and Architecture of Asthma-COPD Overlap

The largest genome-wide association study to date identifies eight signals associated with asthma-COPD overlap that suggest a spectrum of shared genetic influences, from variants predominantly influencing asthma to those predominantly influencing fixed airflow obstruction.

RELATED VISUAL ABSTRACT »


CHEST INFECTIONS

Impact of Time Between Diagnosis and Treatment for Nontuberculous Mycobacterial Pulmonary Disease on Culture Conversion and All-Cause Mortality

It may be reasonable to start antibiotics according to the “watchful waiting” strategy for nontuberculous mycobacterial pulmonary disease, but given the survival benefits, achieving culture conversion is an important goal for patients in need of treatment.

RELATED VISUAL ABSTRACT »


CRITICAL CARE

Aspirin as a Treatment for ARDS: A Randomized, Placebo-Controlled Clinical Trial

Looking at aspirin as a potential therapeutic option for ARDS, original research showed no evidence of improvement in physiological markers of pulmonary or systemic dysfunction with 75 mg daily aspirin.


DIFFUSE LUNG DISEASE

Early Radiographic Progression of Scleroderma: Lung Disease Predicts Long-term Mortality

In two independent multicenter cohorts, radiographic progression of ILD seemed to be a stronger predictor of mortality than longitudinal functional decline in patients with systemic sclerosis.

RELATED VISUAL ABSTRACT »


SLEEP

Effects of CPAP on Metabolic Syndrome in Patients With OSA: A Randomized Trial

Original research shows that 6 months of CPAP therapy in patients with OSA promoted a higher chance of reversing metabolic syndrome as compared with placebo.

RELATED VISUAL ABSTRACT »


Advertisement

 
THORACIC ONCOLOGY

Long-term Survival According to N Stage Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in Non-small Cell LungCancer

Findings support the importance of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in mediastinal staging and may provide a rationale for performing surgery after negative EBUS-TBNA results.


CHEST Journal image

Each month, the journal CHEST® features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine. It also houses our highly regarded clinical practice guidelines and consensus statements.

In addition, readers can find the latest research posted in the Online First section each week and access series that provide insight into relevant clinical areas and address controversial issues, fostering discussion among physicians.

READ THE CURRENT ISSUE

Watch as research comes to life

Our animated videos provide quick synopses of key research from recent issues of the journal CHEST®. The latest video visualizes the findings of original research, “Racial Bias in Pulse Oximetry Measurement Among Patients About to Undergo ECMO in 2019-2020.”

VIEW ALL ANIMATED VIDEOS »

CALL FOR EDITORS IN CHIEF | Build your professional portfolio, and impact patient care by leading one of two new open access journals in the CHEST® portfolio as Editor in Chief.

LEARN MORE ABOUT THE ROLE »

Latest podcasts: Now streaming

CHEST Journal

What did you find most interesting this month? Send us a message @journal_CHEST.

 

Easy viewing. In-depth information.

Watch the latest CHEST journal webinar.

Racial Bias in Pulse Oximetry in Patients About to Undergo ECMO

Watch as authors Michael Sjoding, MD, MSc, and Valeria S. M. Valbuena, MD, MSc, discuss the article, "Racial Bias in Pulse Oximetry Measurement Among Patients About to Undergo ECMO in 2019-2020: A Retrospective Cohort Study," published in the April issue.

Moderators: Alice Gallo de Moraes, MD, and Viren Kaul, MD

Peter J. Mazzone, MD, MPH, FCCP

General Information

Editor in Chief:
Peter J. Mazzone, MD, MPH, FCCP

Published monthly
Archived back to 1935


Submission/Review Stats

Acceptance rate: 9-13% for Original Research

Time to first decision: 3 weeks

Acceptance to publication: 2 to 3 weeks to Online First, 5 months to print

READY TO SUBMIT TO CHEST JOURNAL?
Learn how to submit original research for consideration.

CHEST SUBMISSIONS »

Numbers to be proud of

9.41

Impact Factor

6th

Impact Factor Rank*

2.536

Immediacy Index

.04662

Elgenfactor Score

2.651

Article Influence Score

20th

Google Scholar Rank

*Impact Factor Rank is 6th among 64 journals in the respiratory and critical care system category and 4th among 36 journals in the critical care category | VIEW MORE CITATION DATA »

When you become a member of CHEST, you’ll be automatically subscribed to the journal CHEST and receive alerts on the latest research as well as discounts on all that we offer.

GET THE LATEST RESEARCH UPDATES

Nonmembers and institutions can subscribe by contacting Elsevier Customer Service for assistance or -Tel: + 1 (800) 654-2452 (United States and Canada); + 1 (314) 447-8871 (outside United States and Canada).